Health

A recent phase II study has shown that Hepatic Arterial Infusion Pump (HAIP) chemotherapy with floxuridine has significantly improved overall survival (OS) in patients with advanced intrahepatic cholangiocarcinoma (iCCA). The study conducted by Bas Groot Koerkamp, MD, PhD, of the Erasmus MC Cancer Institute in Rotterdam, the Netherlands, reported that patients treated with HAIP chemotherapy
0 Comments
Long COVID, a condition that affects individuals who have recovered from acute COVID-19 but continue to experience persistent symptoms, remains a mystery to researchers. However, a recent analysis of longitudinal data has shed light on potential factors underlying long COVID. In this study, blood samples from long COVID patients were analyzed, revealing significant changes to
0 Comments
The recent hospitalization of Kate Middleton, the Princess of Wales, following a planned abdominal surgery has sparked worry among her supporters. The princess canceled all engagements until Easter, indicating a significant health issue. The specifics of her condition have not been disclosed, leaving many to speculate about the severity and nature of her surgery. It
0 Comments
In today’s healthcare system, many patients face the challenge of affording their prescribed medications. High costs and limited insurance coverage often force individuals to make difficult choices regarding their healthcare. Real-Time Benefit Tools (RTBTs) have emerged as a potential solution to this problem, providing clinicians with price estimates and lower-cost alternatives for medications. However, a
0 Comments
Childhood trauma has long been associated with a variety of negative outcomes in adulthood, including an increased risk for substance use disorders. In a recent cross-sectional study, researchers explored the potential link between childhood trauma, emotion dysregulation, and nicotine addiction. The study utilized resting-state functional MRI to examine the dynamic patterns of functional coordination in
0 Comments
Community-acquired pneumonia is a significant health concern that often requires hospitalization. Recent research has examined the benefits of adding oral clarithromycin to beta-lactam antibiotic treatment for patients with community-acquired pneumonia who have systemic inflammatory response syndrome. The double-blind ACCESS trial investigated the impact of this combination therapy on clinical response and outcomes. This article critically
0 Comments